Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Vessel Prosthesis Implantation | 8 | 2023 | 208 | 2.260 |
Why?
|
| Endovascular Procedures | 6 | 2023 | 218 | 1.840 |
Why?
|
| Endarterectomy, Carotid | 3 | 2023 | 73 | 1.760 |
Why?
|
| Aortic Aneurysm, Abdominal | 4 | 2023 | 112 | 1.230 |
Why?
|
| Blood Vessel Prosthesis | 5 | 2023 | 228 | 1.210 |
Why?
|
| Carotid Stenosis | 3 | 2023 | 112 | 1.180 |
Why?
|
| Stents | 6 | 2023 | 377 | 0.990 |
Why?
|
| Ischemic Attack, Transient | 2 | 2023 | 181 | 0.980 |
Why?
|
| Stroke | 4 | 2023 | 965 | 0.970 |
Why?
|
| Hospital Costs | 3 | 2023 | 107 | 0.960 |
Why?
|
| Medicare | 3 | 2023 | 410 | 0.910 |
Why?
|
| Aneurysm | 2 | 2020 | 58 | 0.820 |
Why?
|
| Fee-for-Service Plans | 1 | 2020 | 30 | 0.730 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2020 | 59 | 0.720 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2020 | 162 | 0.650 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 220 | 0.620 |
Why?
|
| Hospital Mortality | 1 | 2020 | 350 | 0.620 |
Why?
|
| Pandemics | 2 | 2022 | 740 | 0.590 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2010 | 87 | 0.430 |
Why?
|
| Aorta, Abdominal | 1 | 2010 | 60 | 0.370 |
Why?
|
| Time Factors | 9 | 2020 | 5214 | 0.350 |
Why?
|
| Device Removal | 1 | 2011 | 161 | 0.350 |
Why?
|
| Aorta, Thoracic | 1 | 2010 | 165 | 0.340 |
Why?
|
| Retrospective Studies | 12 | 2023 | 8496 | 0.330 |
Why?
|
| Aged | 13 | 2023 | 18423 | 0.330 |
Why?
|
| Treatment Outcome | 12 | 2023 | 7998 | 0.290 |
Why?
|
| Prosthesis Design | 3 | 2023 | 278 | 0.290 |
Why?
|
| Vascular Surgical Procedures | 2 | 2022 | 148 | 0.290 |
Why?
|
| United States | 4 | 2023 | 6681 | 0.280 |
Why?
|
| Postoperative Complications | 3 | 2018 | 2207 | 0.280 |
Why?
|
| Germ Cells | 2 | 2003 | 126 | 0.270 |
Why?
|
| Mitral Valve | 3 | 2012 | 248 | 0.260 |
Why?
|
| Humans | 24 | 2023 | 86678 | 0.260 |
Why?
|
| Esophageal Perforation | 1 | 2004 | 18 | 0.240 |
Why?
|
| Aged, 80 and over | 7 | 2020 | 6513 | 0.240 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2020 | 40 | 0.230 |
Why?
|
| Infertility, Male | 1 | 2003 | 24 | 0.230 |
Why?
|
| Carotid Arteries | 1 | 2023 | 127 | 0.220 |
Why?
|
| Operating Rooms | 1 | 2023 | 126 | 0.210 |
Why?
|
| Middle Aged | 11 | 2023 | 25040 | 0.200 |
Why?
|
| Subclavian Artery | 2 | 2011 | 44 | 0.190 |
Why?
|
| Diagnosis-Related Groups | 1 | 2020 | 20 | 0.190 |
Why?
|
| Risk Factors | 7 | 2023 | 5420 | 0.190 |
Why?
|
| Academic Medical Centers | 1 | 2023 | 380 | 0.180 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 57 | 0.180 |
Why?
|
| Female | 13 | 2023 | 44550 | 0.180 |
Why?
|
| Hospitals | 1 | 2022 | 294 | 0.180 |
Why?
|
| Emergencies | 1 | 2020 | 113 | 0.180 |
Why?
|
| Cause of Death | 1 | 2020 | 277 | 0.170 |
Why?
|
| Risk Assessment | 4 | 2020 | 2264 | 0.160 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 98 | 0.150 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 455 | 0.150 |
Why?
|
| Patient Safety | 1 | 2020 | 212 | 0.150 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 429 | 0.150 |
Why?
|
| Philadelphia | 3 | 2011 | 16 | 0.150 |
Why?
|
| Celiac Artery | 3 | 2015 | 25 | 0.150 |
Why?
|
| Vascular System Injuries | 1 | 2017 | 29 | 0.150 |
Why?
|
| Male | 14 | 2020 | 40988 | 0.150 |
Why?
|
| Hepatic Artery | 1 | 2017 | 83 | 0.150 |
Why?
|
| Surgeons | 1 | 2021 | 238 | 0.150 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2017 | 107 | 0.140 |
Why?
|
| Hospitals, University | 3 | 2011 | 194 | 0.140 |
Why?
|
| Survival Analysis | 1 | 2020 | 1538 | 0.140 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 1686 | 0.140 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2011 | 516 | 0.130 |
Why?
|
| Brain Ischemia | 1 | 2020 | 398 | 0.130 |
Why?
|
| Thymectomy | 2 | 2006 | 31 | 0.130 |
Why?
|
| Aortic Aneurysm | 1 | 2015 | 80 | 0.130 |
Why?
|
| Myasthenia Gravis | 2 | 2006 | 83 | 0.120 |
Why?
|
| Catheterization | 1 | 2015 | 232 | 0.120 |
Why?
|
| Models, Cardiovascular | 2 | 2012 | 98 | 0.120 |
Why?
|
| Aortography | 2 | 2010 | 63 | 0.120 |
Why?
|
| Spermatogonia | 2 | 2003 | 13 | 0.110 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 1169 | 0.110 |
Why?
|
| Carotid Artery, Common | 1 | 2011 | 29 | 0.100 |
Why?
|
| Vertebral Artery | 1 | 2011 | 23 | 0.100 |
Why?
|
| Length of Stay | 2 | 2015 | 704 | 0.100 |
Why?
|
| Saphenous Vein | 1 | 2011 | 61 | 0.100 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2011 | 344 | 0.100 |
Why?
|
| Endoleak | 1 | 2011 | 35 | 0.100 |
Why?
|
| Foreign-Body Migration | 1 | 2011 | 35 | 0.100 |
Why?
|
| Aortic Rupture | 1 | 2011 | 55 | 0.090 |
Why?
|
| Prosthesis-Related Infections | 1 | 2011 | 58 | 0.090 |
Why?
|
| Treatment Failure | 1 | 2011 | 286 | 0.090 |
Why?
|
| Heart Valve Diseases | 1 | 2011 | 109 | 0.090 |
Why?
|
| Survivors | 1 | 2011 | 226 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2017 | 1271 | 0.090 |
Why?
|
| Reoperation | 1 | 2011 | 597 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2011 | 374 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2011 | 2601 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2010 | 1078 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 663 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 1204 | 0.060 |
Why?
|
| Alkylating Agents | 1 | 2003 | 32 | 0.060 |
Why?
|
| Busulfan | 1 | 2003 | 39 | 0.060 |
Why?
|
| Renal Artery | 2 | 2015 | 64 | 0.050 |
Why?
|
| Fertility | 1 | 2003 | 115 | 0.050 |
Why?
|
| Testis | 1 | 2003 | 152 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 1673 | 0.050 |
Why?
|
| Reproduction | 1 | 2003 | 195 | 0.050 |
Why?
|
| Patient Selection | 2 | 2019 | 686 | 0.050 |
Why?
|
| New Orleans | 1 | 2021 | 6 | 0.050 |
Why?
|
| Finite Element Analysis | 2 | 2012 | 74 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 55 | 0.050 |
Why?
|
| Esophageal Neoplasms | 1 | 2004 | 322 | 0.050 |
Why?
|
| Haplotypes | 1 | 2003 | 642 | 0.050 |
Why?
|
| Stem Cells | 1 | 2003 | 351 | 0.050 |
Why?
|
| Data Mining | 1 | 2020 | 42 | 0.050 |
Why?
|
| Stress, Mechanical | 2 | 2012 | 248 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 364 | 0.050 |
Why?
|
| Natural Language Processing | 1 | 2020 | 37 | 0.050 |
Why?
|
| Leiomyoma | 1 | 2004 | 191 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 2706 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 293 | 0.040 |
Why?
|
| Health Personnel | 1 | 2021 | 202 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2011 | 861 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2011 | 860 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2019 | 136 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 204 | 0.040 |
Why?
|
| Louisiana | 1 | 2017 | 17 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2019 | 272 | 0.040 |
Why?
|
| Logistic Models | 2 | 2011 | 1188 | 0.040 |
Why?
|
| Vascular Patency | 1 | 2017 | 126 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2020 | 320 | 0.040 |
Why?
|
| Survival Rate | 2 | 2011 | 1864 | 0.040 |
Why?
|
| Angiography | 1 | 2017 | 208 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 213 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 257 | 0.040 |
Why?
|
| Health Status | 1 | 2019 | 360 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2003 | 3095 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 1532 | 0.030 |
Why?
|
| Pregnancy | 1 | 2003 | 2894 | 0.030 |
Why?
|
| Mesenteric Arteries | 1 | 2015 | 29 | 0.030 |
Why?
|
| Recurrence | 1 | 2017 | 1139 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2015 | 233 | 0.030 |
Why?
|
| Adult | 4 | 2019 | 25659 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 813 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1802 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 3680 | 0.030 |
Why?
|
| Mice | 2 | 2003 | 11356 | 0.030 |
Why?
|
| Ligation | 1 | 2011 | 51 | 0.030 |
Why?
|
| Intracranial Embolism | 1 | 2011 | 29 | 0.020 |
Why?
|
| Constriction | 1 | 2010 | 27 | 0.020 |
Why?
|
| Animals | 3 | 2010 | 26590 | 0.020 |
Why?
|
| Replantation | 1 | 2010 | 36 | 0.020 |
Why?
|
| Sheep | 1 | 2010 | 239 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2012 | 457 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 2011 | 109 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 114 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2010 | 244 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2012 | 695 | 0.020 |
Why?
|
| Observer Variation | 1 | 2011 | 603 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2010 | 385 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 4214 | 0.020 |
Why?
|
| Child | 1 | 2017 | 6928 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2010 | 1144 | 0.020 |
Why?
|
| Kidney | 1 | 2010 | 1242 | 0.020 |
Why?
|
| Thoracoscopy | 1 | 2004 | 22 | 0.010 |
Why?
|
| Thoracotomy | 1 | 2004 | 58 | 0.010 |
Why?
|
| Esophagus | 1 | 2004 | 102 | 0.010 |
Why?
|
| Lac Operon | 1 | 2003 | 46 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 2003 | 47 | 0.010 |
Why?
|
| Growth Substances | 1 | 2003 | 80 | 0.010 |
Why?
|
| Surgical Stomas | 1 | 2003 | 22 | 0.010 |
Why?
|
| Culture Media | 1 | 2003 | 147 | 0.010 |
Why?
|
| Sternum | 1 | 2002 | 30 | 0.010 |
Why?
|
| Adolescent | 2 | 2006 | 8984 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2003 | 253 | 0.010 |
Why?
|
| Neck | 1 | 2002 | 100 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 2003 | 183 | 0.010 |
Why?
|
| Environment | 1 | 2003 | 219 | 0.010 |
Why?
|
| Remission Induction | 1 | 2002 | 722 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 1566 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2003 | 1540 | 0.010 |
Why?
|
| Cell Line | 1 | 2003 | 2469 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 2819 | 0.010 |
Why?
|